Annual SG&A
$16.85 M
+$459.00 K+2.80%
31 December 2023
Summary:
Pieris Pharmaceuticals annual selling, general & administrative expenses is currently $16.85 million, with the most recent change of +$459.00 thousand (+2.80%) on 31 December 2023. During the last 3 years, it has risen by +$140.00 thousand (+0.84%). PIRS annual SG&A is now -8.62% below its all-time high of $18.44 million, reached on 31 December 2018.PIRS Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$3.58 M
+$155.00 K+4.52%
30 September 2024
Summary:
Pieris Pharmaceuticals quarterly selling, general & administrative expenses is currently $3.58 million, with the most recent change of +$155.00 thousand (+4.52%) on 30 September 2024. Over the past year, it has dropped by -$3.26 million (-47.64%). PIRS quarterly SG&A is now -47.64% below its all-time high of $6.84 million, reached on 30 September 2023.PIRS Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.28 B
-$15.95 M-1.26%
30 September 2024
Summary:
Pieris Pharmaceuticals TTM selling, general & administrative expenses is currently -$1.28 billion, with the most recent change of -$15.95 million (-1.26%) on 30 September 2024. Over the past year, it has dropped by -$1.30 billion (-7039.65%). PIRS TTM SG&A is now -15665741.46% below its all-time high of $20.27 million, reached on 30 September 2018.PIRS TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PIRS Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.8% | -47.6% | -7039.6% |
| 3 y3 years | +0.8% | -13.3% | -8040.4% |
| 5 y5 years | -8.6% | -25.9% | -7036.3% |
PIRS Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +2.8% | -47.6% | +53.9% | -41.8% | at low |
| 5 y | 5 years | -8.6% | +2.8% | -47.6% | +53.9% | -97.5% | at low |
| alltime | all time | -8.6% | -47.6% | >+9999.0% | <-9999.0% | at low |
Pieris Pharmaceuticals Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $3.58 M(+4.5%) | $13.47 M(-19.5%) |
| June 2024 | - | $3.43 M(-17.2%) | $16.73 M(-1.4%) |
| Mar 2024 | - | $4.14 M(+77.8%) | $16.97 M(+0.7%) |
| Dec 2023 | $16.85 M(+2.8%) | $2.33 M(-66.0%) | $16.85 M(-9.0%) |
| Sept 2023 | - | $6.84 M(+86.7%) | $18.51 M(+18.5%) |
| June 2023 | - | $3.66 M(-8.9%) | $15.62 M(-2.6%) |
| Mar 2023 | - | $4.02 M(+1.0%) | $16.04 M(-2.2%) |
| Dec 2022 | $16.39 M(-1.2%) | $3.98 M(+0.9%) | $16.39 M(-0.6%) |
| Sept 2022 | - | $3.95 M(-3.2%) | $16.49 M(-1.1%) |
| June 2022 | - | $4.08 M(-6.8%) | $16.68 M(-1.0%) |
| Mar 2022 | - | $4.38 M(+7.2%) | $16.84 M(+1.5%) |
| Dec 2021 | $16.59 M(-0.7%) | $4.08 M(-1.1%) | $16.59 M(+2.6%) |
| Sept 2021 | - | $4.13 M(-2.7%) | $16.18 M(+0.1%) |
| June 2021 | - | $4.25 M(+2.8%) | $16.16 M(-2.0%) |
| Mar 2021 | - | $4.13 M(+12.5%) | $16.48 M(-1.4%) |
| Dec 2020 | $16.71 M(-9.4%) | $3.67 M(-10.8%) | $16.71 M(-4.6%) |
| Sept 2020 | - | $4.12 M(-9.9%) | $17.53 M(-3.9%) |
| June 2020 | - | $4.57 M(+4.8%) | $18.25 M(+2.1%) |
| Mar 2020 | - | $4.36 M(-2.8%) | $17.87 M(-3.1%) |
| Dec 2019 | $18.44 M(-0.0%) | $4.48 M(-7.3%) | $18.44 M(-0.4%) |
| Sept 2019 | - | $4.83 M(+15.4%) | $18.52 M(+0.5%) |
| June 2019 | - | $4.19 M(-15.1%) | $18.43 M(-3.1%) |
| Mar 2019 | - | $4.93 M(+8.1%) | $19.02 M(+3.1%) |
| Dec 2018 | $18.44 M | $4.56 M(-3.9%) | $18.44 M(-9.0%) |
| Sept 2018 | - | $4.75 M(-0.6%) | $20.27 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | $4.78 M(+9.8%) | $18.38 M(+2.4%) |
| Mar 2018 | - | $4.35 M(-31.9%) | $17.95 M(+2.1%) |
| Dec 2017 | $17.58 M(+97.8%) | $6.39 M(+124.2%) | $17.58 M(+31.2%) |
| Sept 2017 | - | $2.85 M(-34.4%) | $13.40 M(+4.0%) |
| June 2017 | - | $4.35 M(+9.0%) | $12.89 M(+18.1%) |
| Mar 2017 | - | $3.99 M(+80.2%) | $10.91 M(+22.7%) |
| Dec 2016 | $8.89 M(+6.2%) | $2.21 M(-5.4%) | $8.89 M(+5.4%) |
| Sept 2016 | - | $2.34 M(-1.1%) | $8.44 M(+1.2%) |
| June 2016 | - | $2.37 M(+20.3%) | $8.34 M(+5.0%) |
| Mar 2016 | - | $1.97 M(+11.7%) | $7.94 M(-5.1%) |
| Dec 2015 | $8.37 M(+20.2%) | $1.76 M(-21.4%) | $8.37 M(+26.7%) |
| Sept 2015 | - | $2.24 M(+13.9%) | $6.61 M(+50.9%) |
| June 2015 | - | $1.97 M(-17.8%) | $4.38 M(+81.3%) |
| Mar 2015 | - | $2.39 M(>+9900.0%) | $2.41 M(>+9900.0%) |
| Dec 2014 | $6.96 M(>+9900.0%) | - | - |
| Sept 2014 | - | $13.90 K(+143.9%) | $23.30 K(+54.3%) |
| June 2014 | - | $5700.00(+280.0%) | $15.10 K(+60.6%) |
| June 2014 | $15.20 K(-99.4%) | - | - |
| Mar 2014 | - | $1500.00(-31.8%) | $9400.00(+19.0%) |
| Dec 2013 | $2.46 M(>+9900.0%) | $2200.00(-61.4%) | $7900.00(+38.6%) |
| Sept 2013 | - | $5700.00 | $5700.00 |
| June 2013 | $0.00(-100.0%) | - | - |
| June 2003 | $21.30 K(-17.4%) | - | - |
| June 2002 | $25.80 K(+160.6%) | - | - |
| June 2001 | $9900.00 | - | - |
FAQ
- What is Pieris Pharmaceuticals annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals annual SG&A year-on-year change?
- What is Pieris Pharmaceuticals quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals quarterly SG&A year-on-year change?
- What is Pieris Pharmaceuticals TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Pieris Pharmaceuticals?
- What is Pieris Pharmaceuticals TTM SG&A year-on-year change?
What is Pieris Pharmaceuticals annual selling, general & administrative expenses?
The current annual SG&A of PIRS is $16.85 M
What is the all time high annual SG&A for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high annual selling, general & administrative expenses is $18.44 M
What is Pieris Pharmaceuticals annual SG&A year-on-year change?
Over the past year, PIRS annual selling, general & administrative expenses has changed by +$459.00 K (+2.80%)
What is Pieris Pharmaceuticals quarterly selling, general & administrative expenses?
The current quarterly SG&A of PIRS is $3.58 M
What is the all time high quarterly SG&A for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high quarterly selling, general & administrative expenses is $6.84 M
What is Pieris Pharmaceuticals quarterly SG&A year-on-year change?
Over the past year, PIRS quarterly selling, general & administrative expenses has changed by -$3.26 M (-47.64%)
What is Pieris Pharmaceuticals TTM selling, general & administrative expenses?
The current TTM SG&A of PIRS is -$1.28 B
What is the all time high TTM SG&A for Pieris Pharmaceuticals?
Pieris Pharmaceuticals all-time high TTM selling, general & administrative expenses is $20.27 M
What is Pieris Pharmaceuticals TTM SG&A year-on-year change?
Over the past year, PIRS TTM selling, general & administrative expenses has changed by -$1.30 B (-7039.65%)